Anbio Biotechnology (NASDAQ:NNNN) Reaches New 1-Year Low – Here’s What Happened

Anbio Biotechnology (NASDAQ:NNNN)’s share price hit a new 52-week low on Tuesday . The stock traded as low as $6.06 and last traded at $6.11, with a volume of 307649 shares. The stock had previously closed at $6.34.

Analyst Ratings Changes

Separately, Weiss Ratings downgraded Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, July 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.

Anbio Biotechnology Stock Down 3.6%

The firm’s 50 day simple moving average is $8.87 and its 200 day simple moving average is $18.60.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.